Gunda I. Georg

11.2k total citations · 1 hit paper
273 papers, 8.0k citations indexed

About

Gunda I. Georg is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Gunda I. Georg has authored 273 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Organic Chemistry, 116 papers in Molecular Biology and 103 papers in Oncology. Recurrent topics in Gunda I. Georg's work include Cancer Treatment and Pharmacology (76 papers), Synthetic Organic Chemistry Methods (56 papers) and Microtubule and mitosis dynamics (34 papers). Gunda I. Georg is often cited by papers focused on Cancer Treatment and Pharmacology (76 papers), Synthetic Organic Chemistry Methods (56 papers) and Microtubule and mitosis dynamics (34 papers). Gunda I. Georg collaborates with scholars based in United States, Germany and China. Gunda I. Georg's co-authors include Richard H. Himes, Suzanne B. Buck, Sam F. Victory, Micah J. Niphakis, Ashok Rao Tunoori, Jonathan M. White, E. Schönbrunn, Brandon J. Turunen, Mathew P. Martin and Joydeep Kant and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Gunda I. Georg

267 papers receiving 7.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action

1998 811 citations Richard H. Himes, Gunda I. Georg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gunda I. Georg United States	43	4.1k	3.3k	2.3k	1.1k	1.0k	273	8.0k
Nicholas J. Lawrence United States	45	3.1k 0.8×	3.3k 1.0×	1.5k 0.6×	436 0.4×	574 0.6×	143	6.8k
K. C. Nicolaou United States	62	7.7k 1.9×	4.4k 1.3×	1.7k 0.7×	517 0.5×	1.9k 1.9×	156	11.7k
Andrew T. McPhail United States	41	4.9k 1.2×	3.6k 1.1×	2.3k 1.0×	698 0.7×	1.5k 1.5×	410	10.4k
Erik J. Sorensen United States	47	5.7k 1.4×	2.4k 0.7×	1.7k 0.7×	535 0.5×	1.3k 1.2×	133	7.9k
Athanassios Giannis Germany	43	3.0k 0.7×	4.0k 1.2×	818 0.3×	525 0.5×	460 0.5×	196	6.7k
Danuta S. Kalinowski Australia	51	2.3k 0.6×	3.4k 1.0×	3.5k 1.5×	391 0.4×	234 0.2×	113	8.7k
John W. Kozarich United States	43	1.9k 0.5×	5.2k 1.6×	1.7k 0.7×	424 0.4×	344 0.3×	141	7.7k
Chunquan Sheng China	52	4.1k 1.0×	4.5k 1.4×	1.4k 0.6×	174 0.2×	843 0.8×	263	9.3k
Pierre Potìer France	44	4.1k 1.0×	3.3k 1.0×	2.0k 0.9×	561 0.5×	1.2k 1.2×	351	8.2k
Jeffrey D. Winkler United States	43	3.1k 0.8×	2.5k 0.8×	604 0.3×	390 0.4×	404 0.4×	149	6.7k

Countries citing papers authored by Gunda I. Georg

Since Specialization

Citations

This map shows the geographic impact of Gunda I. Georg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunda I. Georg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunda I. Georg more than expected).

Fields of papers citing papers by Gunda I. Georg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunda I. Georg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunda I. Georg. The network helps show where Gunda I. Georg may publish in the future.

Co-authorship network of co-authors of Gunda I. Georg

This figure shows the co-authorship network connecting the top 25 collaborators of Gunda I. Georg. A scholar is included among the top collaborators of Gunda I. Georg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunda I. Georg. Gunda I. Georg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Kyle, Wendy A. Hudson, Gunda I. Georg, et al.. (2025). Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. Molecular Cancer Therapeutics. 25(2). 230–243.

Giarolla, Jeanine, et al.. (2025). Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry. 17(5). 607–627. 1 indexed citations

Liang, T. Jake, Jonathan Solberg, Rui Shi, et al.. (2025). Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors. European Journal of Medicinal Chemistry. 290. 117504–117504.

Shi, Rui, Debra J. Wolgemuth, & Gunda I. Georg. (2025). Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review. Contraception. 145. 110809–110809. 2 indexed citations

Cuellar, Rebecca A. D., Sanny S.W. Chung, H.L.S. Wong, et al.. (2023). Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception. European Journal of Medicinal Chemistry. 261. 115821–115821. 7 indexed citations

Faber, Erik B., Nan Wang, An‐Suei Yang, et al.. (2023). Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding. Nature Communications. 14(1). 27 indexed citations

Shameem, Mohammad, et al.. (2023). Mitochondria‐targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species. Molecular Carcinogenesis. 62(11). 1619–1629. 11 indexed citations

Zhou, Julie, Brenda S. Magenheimer, Gail A. Reif, et al.. (2022). The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease. American Journal of Physiology-Renal Physiology. 323(4). F492–F506. 1 indexed citations

Berndt, Norbert, et al.. (2022). Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. Journal of Medicinal Chemistry. 65(15). 10441–10458. 12 indexed citations

10.

Francis, Rawle, et al.. (2022). Discovery and Characterization of Multiple Classes of Human CatSper Blockers. ChemMedChem. 17(15). e202000499–e202000499. 19 indexed citations

11.

Hong, Kwon Ho, et al.. (2021). Tetrahydroindazole inhibitors of CDK2/cyclin complexes. European Journal of Medicinal Chemistry. 214. 113232–113232. 6 indexed citations

12.

Baxley, Ryan M., Fredy Kurniawan, Rawle Francis, et al.. (2019). The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10. Open Biology. 9(8). 190117–190117. 11 indexed citations

13.

Hanna, Carol, Shan Yao, E. Schönbrunn, et al.. (2019). Identification and Screening of Selective WEE2 Inhibitors to Develop Non‐Hormonal Contraceptives that Specifically Target Meiosis. ChemistrySelect. 4(45). 13363–13369. 7 indexed citations

14.

Gupta, Vijayalaxmi, J. Zhu, Joseph S. Tash, et al.. (2017). Structure–Activity Studies of N‐Butyl‐1‐deoxynojirimycin (NB‐DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2. ChemMedChem. 12(23). 1977–1984. 13 indexed citations

15.

Sajjad, M. Arif, Ufana Riaz, Rutao Yao, et al.. (2012). Investigation of 3′-debenzoyl-3′-(3-([124I]-iodobenzoyl))paclitaxel analog as a radio-tracer to study multidrug resistance in vivo. Applied Radiation and Isotopes. 70(8). 1624–1631. 2 indexed citations

16.

Turunen, Brandon J., Haibo Ge, Kelly E. Desino, et al.. (2008). Paclitaxel succinate analogs: Anionic and amide introduction as a strategy to impart blood–brain barrier permeability. Bioorganic & Medicinal Chemistry Letters. 18(22). 5971–5974. 18 indexed citations

17.

Spletstoser, Jared T., Jonathan M. White, Ashok Rao Tunoori, & Gunda I. Georg. (2007). Mild and Selective Hydrozirconation of Amides to Aldehydes Using Cp₂Zr(H)Cl: Scope and Mechanistic Insight. Journal of the American Chemical Society. 129(11). 3408–3419. 201 indexed citations

18.

Ahn, Yu Mi, Lakshminarayana Vogeti, Hari Krishna R. Santhapuram, et al.. (2006). Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues. Bioorganic & Medicinal Chemistry. 15(2). 702–713. 29 indexed citations

19.

Ahn, Yu Mi, et al.. (2001). ChemInform Abstract: A Convenient Method for the Efficient Removal of Ruthenium By‐Products Generated During Olefin Metathesis Reactions.. ChemInform. 32(34). 4 indexed citations

20.

Georg, Gunda I. & Manfred Haake. (1983). A New Method for the Synthesis of Diaryl Sulfone Diimides andsec-Alkyl Aryl Sulfone Diimides. Synthesis. 1983(11). 919–919. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact